Digital health app for fatty liver disease
Part of Digestive system, Hormones & metabolism clinical trials.
This trial tests a digital health app designed to help people with metabolic-associated fatty liver disease (MAFLD). The app provides diet and exercise guidance to improve liver health.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- You have a body mass index (BMI) between 24 and 35.
- You have been diagnosed with fatty liver disease related to metabolism (MAFLD) based on a FibroScan or MRI test.
- You have a smartphone that can run the study app.
- If you have type 2 diabetes, your medications have been stable for at least 3 months.
- You are not a heavy drinker (more than 3 drinks a day for men, 2 for women) within the past year.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a digital app to help people with fatty liver disease (MASLD) manage their condition. It's for adults who are comfortable using a smartphone or have someone to help them.
This trial tests a digital diet and exercise program to help reduce liver scarring in people with fatty liver disease. You'll use an app or online tool to follow healthy eating and activity routines, which may slow or reverse liver damage.
This study tests whether an app that uses artificial intelligence to guide your lifestyle changes works better than a standard lifestyle program for people with fatty liver disease. If you have fatty liver and are overweight, this trial could help you reduce liver fat and improve your health.
This research studies fatty liver disease linked to metabolic problems like diabetes and obesity. You'll wear a fitness tracker and have liver imaging to help doctors understand the disease and find new treatments.
This trial tests whether taking a synbiotic (a mix of helpful bacteria and fiber) can improve insulin levels and reduce inflammation in people with Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD). It may help by changing the balance of bacteria in your gut.
This trial tests a digital lifestyle program (diet and activity coaching) to help people with HIV and fatty liver disease lose weight. It aims to see if the program can reduce body fat in the liver and improve overall health.
Hear when a new MAFLD trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.